Yessotoxin affects fMLP-induced cell shape changes in Mytilus galloprovincialis immunocytes

Cell Biology International

Volumn 28, Issue 1, 2004, Pages 57-61

  Malagoli, Davide ^a   Ottaviani, Enzo ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Calcium; cAMP; Cell motility; Immunocytes; Mytilus galloprovincialis; Signalling pathways; Yessotoxin

Indexed keywords

CALCIUM CHANNEL L TYPE; CALCIUM ION; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; PHOSPHATIDYLINOSITOL 3 KINASE; PLANT TOXIN; PROTEIN KINASE C; UNCLASSIFIED DRUG; YESSOTOXIN;

ANIMAL CELL; ARTICLE; CALCIUM SIGNALING; CELL ACTIVATION; CELL MOTILITY; CELL SHAPE; CELL STRUCTURE; COMPUTER ANALYSIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; EXTRACELLULAR CALCIUM; IMAGE ANALYSIS; IMMUNE RESPONSE; LYMPHOCYTE; MUSSEL; MYTILUS GALLOPROVINCIALIS; NONHUMAN;

ALGAE; MYTILUS GALLOPROVINCIALIS;

EID: 0842265858     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellbi.2003.10.003     Document Type: Article

References (35)

1. Alfonso A., De La Rosa L., Vieytes M.R., Yasumoto T., Botana L.M. Yessotoxin, a novel phycotoxin, activates phosphodiesterase activity. Effect of yessotoxin on cAMP levels in human lymphocytes. Biochem Pharmacol. 65:2003;193-208.
2. Arcaro A., Wymann M.P. Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-triphosphate in neutrophil responses. Biochem J. 296:1993;297-301.
3. Aune T., Sørby R., Yasumoto T., Ramstad H., Landsverk T. Comparison of oral and intraperitoneal toxicity of yessotoxin towards mice. Toxicon. 40:2002;77-82.
4. 2+influx. J Neurochem. 74:2000;1443-1451.
5. Berridge M.J. Inositol triphosphate and calcium signalling. Nature. 361:1993;315-325.
6. Cass L.A., Summers S.A., Prendergast G.V., Backer J.M., Birnbaum M.J., Meinkoth J.L. Protein kinase A-dependent and independent signaling pathways contribute to cyclic AMP-stimulated proliferation. Mol Cell Biol. 19:1999;5882-5891.
7. Chijiwa T., Mishima A., Hagiwara M., Sano M., Hayashi K., Inoue T., et al. Inhibition of fosfokolin-induced neurite outgrowth and protein phosphorylation by a newly synthesised selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylammino)ethyl]-5- isoquinolinesulfonamide (H89), of PC12D pheochromocytoma cells. J Biol Chem. 265:1990;5267-5272.
8. Ciminiello P., Fattorusso E., Forino M., Magno S., Poletti R., Viviani R. Isolation of adriatoxin, a new analogue of yessotoxin from mussels of the Adriatic Sea. Tetrahedron Lett. 39:1998;8897-8900.
9. Ciminiello P., Fattorusso E., Forino M., Magno S., Poletti R., Viviani R. A new analog of yessotoxin, carboxyyessotoxin, isolated from Adriatic Sea mussels. Eur J Org Chem. 00:2000;291-295.
10. de la Rosa L., Alfonso A., Vilarino N., Vieytes M.R., Botana L.M. Modulation of cytosolic calcium levels of human lymphocytes by yessotoxin, a novel marine phycotoxin. Biochem Pharmacol. 61:2001a;827-833.
11. 2+channel blockers and kinases. Cell Signal. 13:2001b;711-716.
12. Fleckenstein A. Basic membrane actions of calcium antagonists with special reference to verapamil. Godfraind T., Alberini A., Paoletti R. Calcium modulators. 1982;297-310 Elsevier Biomedical Press, Amsterdam.
13. Franchini A., Milandri A., Poletti R., Ottaviani E. Immunolocalization of yessotoxin in the mussel Mytilus galloprovincialis. Toxicon. 41:2003;967-970.
14. 2+signals in cultured rat myotubes. Br J Pharmacol. 137:2002;1055-1062.
15. Holgate S.T., Lewis R.A., Austen K.F. Role of adenylate cyclase in immunologic release of mediators from rat mast cells: agonist and antagonist effects of purine- and ribose-modified adenosine analogs. Proc Natl Acad Sci U S A. 77:1980;6800-6804.
16. Kavalali E.T., Hwang K.S., Plummer M.R. cAMP-dependent enhancement of dihydropyridine-sensitive calcium channel availability in hippocampal neurons. J Neurosci. 17:1997;5334-5348.
17. +channel. Brain Res. 959:2003;120-127.
18. Malagoli D., Gobba F., Ottaviani E. Effects of 50 Hz magnetic fields on the signalling pathways of fMLP-induced shape changes in invertebrate immunocytes: the activation of an alternative "stress pathway" Biochim Biophys Acta. 1620:2003;185-190.
19. Malaguti C., Ciminiello P., Fattorusso E., Rossini G.P. Caspase activation and death induced by yessotoxin in HeLa cells. Toxicol in Vitro. 16:2002;357-363.
20. McDonald T.F., Pelzer S., Trautwein W., Pelzer D. Regulation and modulation of calcium channels in cardiac, skeletal and smooth muscle cells. Physiol Rev. 74:1994;365-507.
21. Murata T., Kumagai M., Lee J.S., Yasumoto T. Isolation and structure of yessotoxin, a novel polyether compound implicated in diarrhetic shellfish poisoning. Tetrahedron Lett. 28:1987;5869-5872.
22. Nishikawa T., Susano H., Omura M., Suematsu S. Regulation of expression of the steroidogenic acute regulatory (StAR) protein by ACTH in bovine adrenal fasciculata cells. Biochem Biophys Res Commun. 223:1996;12-18.
23. Ogino H., Kumagi M., Yasumoto T. Toxicological evaluation of yessotoxin. Nat Toxins. 5:1997;255-259.
24. Ottaviani E., Franceschi F. The invertebrate phagocytic immunocyte: clues to a common evolution of immune and neuroendocrine systems. Immunol Today. 18:1997;169-174.
25. Ottaviani E., Franchini A., Franceschi C. Pro-opiomelanocortin-derived peptides, cytokines and nitric oxide in immune responses and stress: an evolutionary approach. Int Rev Cytol. 170:1997a;79-141.
26. Ottaviani E., Sassi D., Kletsas D. PDGF- and TGF-β-induced changes in cell shape of invertebrate immunocytes: effect of calcium entry blockers. Eur J Cell Biol. 74:1997b;336-347.
27. Putney J.W. Capacitative calcium entry revised. Cell Calcium. 11:1990;611-624.
28. Satake M., Terasawa K., Kadowaki Y., Yasumoto T. Relative configuration of yessotoxin and isolation of two new analogs from toxic scallops. Tetrahedron Lett. 37:1996;5955-5958.
29. Satake M., Tubaro A., Lee J.-S., Yasumoto T. Two new analogs of yessotoxin, homoyessotoxin and 45-hydroxyhomoyessotoxin, isolated from mussels of the Adriatic Sea. Nat Toxins. 5:1997a;107-110.
30. Satake M., Mackenzie L., Yasumoto T. Identification of Protoceratium reticulatum as the biogenic origin of yessotoxin. Nat Toxins. 5:1997b;164-167.
31. Schön J.C., Torre-Bueno J., Stefano G.B. Microscopic computer-assisted analysis of conformational state: reference to neuroimmunology. Adv Neuroimmunol. 1:1991;252-259.
32. Tamaoki T. Use and specificity of staurosporine, UCN-01 and Calphostin C as protein kinase inhibitors. Methods Enzymol. 201:1991;340-347.
33. Terao K., Ito E., Oarada M., Murata M., Yasumoto T. Histopathological studies on experimental marine toxin poisoning-5. The effects in mice of yessotoxin isolated from Patinopecten yessoensis and of a desulfated derivative. Toxicon. 9:1990;1095-1104.
34. Wieprecht M., Wieder T., Geilen C.C. N-[2-Bromocinnamyl(amino)ethyl]-5- isoquinolinesulfonamide inhibits incorporation of choline into phosphatidylcholine via inhibition of choline kinase and has no effect on the phosphorylation of CTP: phosphocholine cytidiltransferase. Biochem J. 297:1994;241-247.
35. 2+entry in cultured rat cerebellar astrocytes. J Neurochem. 73:1999;1318-1328.